5-fluoropyrimidine has been researched along with Lymph Node Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, J; Jiang, Y; Liao, W; Lin, L; Pan, C; Su, Y; Sun, L; Zhang, J | 1 |
| Araki, K; Dabanaka, K; Hanazaki, K; Hokimoto, N; Kobayashi, M; Maeda, H; Munekage, M; Namikawa, T; Okabayashi, T; Sugimoto, T | 1 |
2 other study(ies) available for 5-fluoropyrimidine and Lymph Node Metastasis
| Article | Year |
|---|---|
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Female; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Pyrimidines; Retrospective Studies; Signal Transduction; Stomach Neoplasms; Survival Analysis; Tumor Burden; Tumor Suppressor Proteins | 2015 |
A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival.
Topics: Adenocarcinoma; Disease-Free Survival; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Pyrimidines; Stomach Neoplasms; Time Factors | 2009 |